NCT02215538View on ClinicalTrials.gov

OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

June 30, 2006

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

OROS methylphenidate

DRUG

Placebo

Placebo medication appears identical to the active medication OROS methylphenidate

Trial Locations (1)

84105

Mood Disorders Clinic, Salt Lake City

All Listed Sponsors
collaborator

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

INDUSTRY

lead

University of Utah

OTHER

NCT02215538 - OROS Methylphenidate (Concerta) in the Treatment of Adult ADHD | Biotech Hunter | Biotech Hunter